Orphan Solutions

Orphan Solutions appears to be a specialized rare-disease and orphan-drug advisory business rather than a therapeutics developer. Public references tie the name to Dr. Marlene Haffner, former longtime director of the FDA Office of Orphan Products Development, and describe the organization as providing orphan-drug development, regulatory, and strategic guidance. Available evidence suggests it supports patient foundations, emerging biopharma companies, and rare-disease programs with development planning rather than operating a proprietary drug pipeline. The entity is healthcare-related, but it does not appear to be a clinical-stage biotech, pharmaceutical manufacturer, or platform-technology company.